Characteristics for patients treated with endovascular therapy
| 2019 n=55 | COVID-19 n=57 | P | |
| Patients per week, mean (SD) | 3.9 (2.2) | 4.1 (2.5) | 0.87 |
| Age median (IQR) | 68 (59, 77) | 69 (62, 81) | 0.28 |
| Sex % male (n) | 64% (35) | 46% (26) | 0.06 |
| Race % white (n) | 62% (34) | 67% (38) | 0.59 |
| Transfer, % (n) | 78% (43) | 68% (39) | 0.24 |
| Comorbidity count mean (SD) | 2 (2) | 2 (1) | 0.44 |
| Time from arrival to groin puncture, minutes | 38 (32, 46) | 43 (38, 64) | 0.002 |
| Time from onset to arrival, minutes | 310 (139, 634) | 221 (121, 417) | 0.14 |
| Time from arrival to recanalization, minutes | 62 (52, 82) | 58 (51, 107) | 0.64 |
| Door to needle time, minutes | 15 (9) | 20 (6) | 0.30 |
| tPA prior to arrival, % (n) | 31% (17) | 37% (21) | 0.51 |
| IV tPA treatment on arrival, % (n) | 11% (6) | 9% (5) | 0.76 |
| Intubated, % (n) | 45% (25) | 96% (55) | <0.0001 |
| Re-intubated, % (n) | 4% (2) | 7% (4) | 0.68 |
| Time to extubation, days, median (IQR) | 2 (1, 3) | 2 (1, 2) | 0.27 |
| Total days intubated, median (IQR) | 2 (1, 3) | 2 (1, 2) | 0.19 |
| Number of times intubated, median (IQR) | 1 (1, 1) | 1 (1, 1) | 0.93 |
| TICI score 2B, 2C or 3 | 85% (46) | 92% (47) | 0.26 |
| ICU LOS | 2 (2, 5) | 2 (1, 3) | 0.26 |
| HLOS | 5 (3, 12) | 6 (4, 9) | 0.73 |
| mRS discharge, median (IQR) | 4 (2, 5) | 4 (3, 5) | 0.84 |
| Discharge disposition | |||
| Home/home health | 29% (16) | 25% (14) | 0.59 |
| Hospice | 15% (8) | 23% (13) | 0.26 |
| Death | 7% (4) | 9% (5) | >0.99 |
| SNF or LTAC | 13% (7) | 9% (5) | 0.5 |
| Rehab or other acute care | 36% (20) | 35% (20) | 0.89 |
ET, endovascular therapy; HLOS, hospital length of stay; ICU LOS, intensive care unit length of stay; IQR, interquartile range; IV, intravenous; LTAC, long-term acute care; mRS, modified Rankin Scale; SD, standard deviation; SNF, skilled nursing facility; TICI, thrombolysis in cerebral infarction; tPA, tissue plasminogen activator.